Search

Jeffrey E. Russel

Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809
Total Applications
3437
Issued Applications
2371
Pending Applications
237
Abandoned Applications
837

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9205021 [patent_doc_number] => 20140004198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'GLP-1 PARTICLES AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/980166 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13773 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980166 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/980166
GLP-1 PARTICLES AND COMPOSITIONS Jan 18, 2012 Abandoned
Array ( [id] => 9307080 [patent_doc_number] => 20140045754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'GLP-1 COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/980147 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12202 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980147 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/980147
GLP-1 COMPOSITIONS Jan 18, 2012 Abandoned
Array ( [id] => 8301023 [patent_doc_number] => 20120183582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Oral Delivery of Peptides' [patent_app_type] => utility [patent_app_number] => 13/342133 [patent_app_country] => US [patent_app_date] => 2012-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12102 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13342133 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/342133
Oral Delivery of Peptides Jan 1, 2012 Abandoned
Array ( [id] => 9413614 [patent_doc_number] => 08697651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Amyloid β fibrillogenesis-inhibiting peptide' [patent_app_type] => utility [patent_app_number] => 13/328315 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7055 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328315 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/328315
Amyloid β fibrillogenesis-inhibiting peptide Dec 15, 2011 Issued
Array ( [id] => 9046821 [patent_doc_number] => 08541375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 13/328284 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23319 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328284 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/328284
Glycopeptide phosphonate derivatives Dec 15, 2011 Issued
Array ( [id] => 8128343 [patent_doc_number] => 20120088716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'Polypeptide Protracting Tags' [patent_app_type] => utility [patent_app_number] => 13/327378 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27053 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088716.pdf [firstpage_image] =>[orig_patent_app_number] => 13327378 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/327378
Polypeptide protracting tags Dec 14, 2011 Issued
Array ( [id] => 10169337 [patent_doc_number] => 09200038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Cyclosporine analogue molecules modified at amino acid 1 and 3' [patent_app_type] => utility [patent_app_number] => 13/994707 [patent_app_country] => US [patent_app_date] => 2011-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18571 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994707 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/994707
Cyclosporine analogue molecules modified at amino acid 1 and 3 Dec 13, 2011 Issued
Array ( [id] => 8173584 [patent_doc_number] => 20120108519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'NEO-TRYPTOPHAN' [patent_app_type] => utility [patent_app_number] => 13/324976 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16584 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108519.pdf [firstpage_image] =>[orig_patent_app_number] => 13324976 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/324976
NEO-TRYPTOPHAN Dec 12, 2011 Abandoned
Array ( [id] => 9160971 [patent_doc_number] => 20130309247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'DIMERIC IAP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/993198 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28382 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993198 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/993198
Dimeric IAP inhibitors Dec 12, 2011 Issued
Array ( [id] => 9081060 [patent_doc_number] => 20130266590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'DIMERIC IAP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/993180 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20485 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993180 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/993180
DIMERIC IAP INHIBITORS Dec 12, 2011 Abandoned
Array ( [id] => 8496429 [patent_doc_number] => 20120295837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'NOVEL ANTIMICROBIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/314288 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29061 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314288 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/314288
NOVEL ANTIMICROBIAL AGENTS Dec 7, 2011 Abandoned
Array ( [id] => 8265823 [patent_doc_number] => 20120165252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Method of Regulating Glucose Metabolism, and Reagents Related Thereto' [patent_app_type] => utility [patent_app_number] => 13/297522 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19230 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13297522 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/297522
Method of regulating glucose metabolism, and reagents related thereto Nov 15, 2011 Issued
Array ( [id] => 9869257 [patent_doc_number] => 08957028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Red-shifted opsin molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/295750 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 20352 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295750 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/295750
Red-shifted opsin molecules and uses thereof Nov 13, 2011 Issued
Array ( [id] => 9882748 [patent_doc_number] => 08969513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Caspofungin analog and applications thereof' [patent_app_type] => utility [patent_app_number] => 13/884750 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9339 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884750 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/884750
Caspofungin analog and applications thereof Nov 9, 2011 Issued
Array ( [id] => 9923084 [patent_doc_number] => 08981048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Caspofungin analog, and preparation method and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/884775 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8498 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884775 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/884775
Caspofungin analog, and preparation method and uses thereof Nov 9, 2011 Issued
Array ( [id] => 9016493 [patent_doc_number] => 20130231457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'PREPARATION METHOD FOR CASPOFUNGIN' [patent_app_type] => utility [patent_app_number] => 13/884686 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5158 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884686 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/884686
Preparation method for caspofungin Nov 9, 2011 Issued
Array ( [id] => 9503522 [patent_doc_number] => 08741835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment' [patent_app_type] => utility [patent_app_number] => 13/287211 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 16835 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287211 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/287211
Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment Nov 1, 2011 Issued
13/287102 COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS Oct 31, 2011 Abandoned
Array ( [id] => 7807999 [patent_doc_number] => 20120058953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 13/274142 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25711 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058953.pdf [firstpage_image] =>[orig_patent_app_number] => 13274142 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/274142
COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS Oct 13, 2011 Abandoned
Array ( [id] => 10893070 [patent_doc_number] => 08916683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Nanostructured physically-associating hydrogels for injectable, responsive, and tough biomaterials' [patent_app_type] => utility [patent_app_number] => 13/253485 [patent_app_country] => US [patent_app_date] => 2011-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 30 [patent_no_of_words] => 13285 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13253485 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/253485
Nanostructured physically-associating hydrogels for injectable, responsive, and tough biomaterials Oct 4, 2011 Issued
Menu